John D. Torres - 04 Feb 2025 Form 4 Insider Report for LENNOX INTERNATIONAL INC (LII)

Signature
/s/ Monica Brown, attorney-in-fact for John Torres
Issuer symbol
LII
Transactions as of
04 Feb 2025
Net transactions value
-$1,197,594
Form type
4
Filing time
05 Feb 2025, 15:49:48 UTC
Previous filing
11 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LII Common Stock, Par Value $0.01 Per Share Options Exercise $335,223 +1,020 +24% $328.65 5,289 04 Feb 2025 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Options Exercise $286,295 +1,103 +21% $259.56 6,392 04 Feb 2025 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Disposed to Issuer $404,775 -695 -11% $582.41 5,697 04 Feb 2025 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Disposed to Issuer $373,325 -641 -11% $582.41 5,056 04 Feb 2025 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Sale $416,552 -715 -14% $582.59 4,341 04 Feb 2025 Direct F1
transaction LII Common Stock, Par Value $0.01 Per Share Sale $166,457 -285 -6.6% $584.06 4,056 04 Feb 2025 Direct
transaction LII Common Stock, Par Value $0.01 Per Share Sale $458,003 -787 -19% $581.96 3,269 04 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LII Non-qualified Stock Appreciation Right Options Exercise $0 -1,020 -100% $0.000000 0 04 Feb 2025 Common Stock, Par Value $0.01 Per Share 1,020 $328.65 Direct F2
transaction LII Non-qualified Stock Appreciation Right Options Exercise $0 -1,103 -50% $0.000000 1,104 04 Feb 2025 Common Stock, Par Value $0.01 Per Share 1,103 $259.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a weighted average sale price of $582.59 at prices ranging from $582.410 to $583.130 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2 One third of the Stock Appreciation Rights became exercisable on 12/10/2022 and each year thereafter. The entire grant became fully exercisable on 12/10/2024.
F3 One third of the Stock Appreciation Rights became exercisable on 12/09/2023 and each year thereafter. The entire grant will become fully exercisable on 12/09/2025.